AUTHORSHIP ISSUES {#sec1-1}
=================

Authorship of a scientific paper indicates that the authors should be credited with creation of new knowledge, offering new solutions, or providing novel insights. It establishes the link between the new idea or discovery and its originator. This is associated with rewards, material, and beyond. The authors earn credit points in performance appraisals, for promotions in the organization, and for better positions elsewhere. Authorship brings recognition from peers and experts in the field. There are financial benefits to be reaped in the form of patents and grants for new research projects. This way, authorship of a research paper has the potential of offering cascading material benefits. No wonder, then, that, in the world of scholarship, authorship is very much sought after. The attractiveness of and value attached to authorship spur scientists to plan and execute research projects and publish them in reputed journals. However, the very same factors also entice scientists to indulge in unethical behaviors and crave for authorship even when they do not deserve it. This communication intends to shed some light on some of these behaviors.

WHO IS AN AUTHOR? {#sec1-2}
=================

An author is defined as the one who begins or creates;\[[@ref1]\] or the one who starts a plan or an idea.\[[@ref2]\] For research publications, an "author" is generally considered to be someone who has made substantive intellectual contributions to a published study.\[[@ref3]\] Providing credit to someone who is not qualified as an author or depriving a deserving scientist of authorship credit are grave ethical issues and have serious implications. In 1985, the International Committee of Medical Journal Editors (ICMJE) first recommended certain criteria for authorship within the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. These have been updated in 2009 \[[Table 1](#T1){ref-type="table"}\].\[[@ref4]\]

###### 

Authorship criteria\[[@ref4]\]
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The Council of Scientific Editors (CSE) describes a range of inappropriate authorships including "Guest" authorship, "honorary," or "gift" authorship, "ghost" authorship and "anonymous" authorship. As authors are expected to take public responsibility for the article and its content; scientists should not publish their scientific reports under pseudonyms or in an anonymous manner. The CSE states that journal editors may allow for anonymous report only when the author fears that revealing the identity could threaten his/her life or lead to loss of livelihood.\[[@ref5]\]

HONORARY AUTHORSHIP {#sec1-3}
===================

"Gift" authorship or "honorar"' authorship is the one that is based on, at best, a tenuous relationship with the manuscript. Many authors include "guest" authorship under "gift" or "honorary" authorship although CSE describes \"Guest\" authorship as the one that is bestowed upon individuals, who have not worked for it, with the perception that their association with the paper will enhance its prestige and augment chances of acceptance by the Journal. As the difference between "guest" authorship and "honorary" or "gift" authorship is marginal; this communication will include "guest" and "gift" authorship under "honorary" authorship.

Over the years, surveys have estimated the prevalence of guest/honorary authorship to be at 11-60%.\[[@ref6]--[@ref12]\] Articles with over five authors are more likely to have "honorary authors" than those with three or lesser number of authors.\[[@ref6]\] Authorships are more often gifted to colleagues with lower academic rank or to those with fewer publications in last few years, to the departmental head\[[@ref13]\] and to those performing various non-author tasks such as reviewing or approving manuscript before submission, providing care, recruiting study subjects, supervising or recruiting co-authors, and contributing illustrations.\[[@ref13]\] Although gift authorship is generally frowned upon, there is a counter-view as well. Some researchers believe that today, the research groups have complex and tangled structure. When some individuals are working on research and publication, others in the group are carrying out their routine clinical or surgical work (basically non-author tasks), allowing the authors to carry on leisurely with research and writing work. This, they think, should be construed as a "passive contribution" to overall scientific goal and should be rewarded with authorship.\[[@ref14]\] Some also justify authorship being granted to departmental head, with whose munificence the research is conducted.

However, most journals do not buy these arguments and discourage the practice of gifting authorships to those who have not made significant contribution. Medical journals have adopted various measures to discourage the practice of honorary authorship \[[Table 2](#T2){ref-type="table"}\].

###### 

Measures taken by various journals to discourage guest authorship
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This practice is believed to be primarily responsible for the over inflation in the number of authors per article in biomedical journals.\[[@ref15][@ref16]\] It is possible that a part of the increase in the number of authors per article could be explained on the basis of complexity of the research in the 21^st^ century requiring collaborations. However, biomedical research has not become more complex than basic science research, which is not witnessing a similar trend.

Before we enumerate policies and actions that would discourage or curb this practice, one has to understand the reasons for which "honorary" authorships are gifted or received. In today\'s competitive world, the motto is "publish or perish." This puts undue pressure on all the scientists to publish as many research papers as possible. The evaluation systems also look for quantity rather than quality of research publications.\[[@ref5]\] No wonder then that everyone is on the lookout for "earning" as many authorships, as possible. At times, junior researchers are not averse to gifting authorships to senior colleagues so as to oblige them and increase the probability of better assessment scores or just to maintain good relations. They also think that having a senior member of the faculty in the byline enhances the chances of acceptance for publication. At times, there is a "quid pro quo" or "reciprocal" arrangement, under which authorships are gifted to repay favors. Many believe that it is a good way of improving camaraderie among the team members and to motivate them.\[[@ref17]\] It is not uncommon to find departments wherein there is an unwritten rule that the name of the head of the department (or head of the clinical unit) is to be included in every paper, as research is possible only because of his or her benevolence. At times, names of junior colleagues are included to ensure that they get a "boost" early in their career.

Junior colleagues, given their inexperience and vulnerable position, are at a distinct disadvantage while negotiating authorship issues ("gift" authorship for a senior colleague or order of authorship). The senior colleagues' greed and insincerity often sabotage efforts towards having an honest and authentic author list. Many senior colleagues who are intelligent, greedy, and ambitious, but are too lazy to put in the hard work and are unable to distinguish moral right from wrong (Kwok calls them "white bulls")\[[@ref18]\] have several tricks up their sleeves for extracting benefits from their juniors. They do not depend on power asymmetry and coercive methods, alone. They also know that simple fraud and scientific dishonesty are easy to detect and difficult to justify. They also realize that total disregard for the ICMJE guidelines would be too risky and open to exposure.\[[@ref18]\] Hence, they demonstrate a public involvement in one or more of the authorship criteria by discussing study design and enrollment plans, reviewing study progress, and agreeing to provide inputs for the manuscript drafts at faculty meetings. At all stages, they put in only a token effort; but if challenged, it is difficult to prove that it did not amount to "significant" contribution. They also interfere with the order in the author list. The position of the first author is "most valued"; as it is generally believed that the first author is the one who has done the maximum work on the project. The "white bulls" try to usurp this position by pressurizing junior colleagues to surrender the first author position. If this is difficult to achieve, they employ another ploy of shifting their name to the end of the author list but assume the role of "guarantor" or "corresponding author"; thereby giving the impression that he needs to be accorded the maximum credit for the work.\[[@ref18]\] Juniors help them by not protesting and institutions help them by trying to keep these matters under the wraps. Many a times, whistleblowers who unmask scientific fraud get discredited, while the senior colleagues involved in the fraud go unpunished. This discourages ethical researchers to protest against or expose frauds.

While on the topic of "first authorship," the dilemma of post-graduate teachers is worth mentioning. In Indian setting, the post-graduate teacher (guide) usually provides the idea for dissertation for post-graduate studies and designs the research study. The data collection is usually done by the post-graduate student and the teacher plays an important role in amending and finalizing the dissertation draft. The question of "who should be the first author" comes up when the dissertation is to be published. The matter gets more complicated when the student does not show any inclination to write it up as a research article.\[[@ref19]\] It has been suggested that in such an eventuality, the guide should provide a reasonable time period for preparing the first draft of the manuscript.\[[@ref20]\] Under all circumstances, it is logical to suggest that the sequence of authors should be determined by their relative overall contributions to the research study and publication\[[@ref20]\] and that all authorship disputes should be resolved before the manuscript is submitted to a journal and that the authors cannot expect the editor to get embroiled with these issues.\[[@ref21]\]

When a senior colleague requests for authorship in a research article, where he played no role; how should a junior colleague handle it? Daniel Sokol\[[@ref22]\] suggests a way out. He says that it would be prudent to refuse the request explaining that the journal requires him to sign a form stating that all authors satisfy authorship criteria. It is best to avoid giving a detailed justification for refusing to oblige invoking words such as honesty, trust, fairness, professionalism, and academic integrity. That would highlight the inappropriateness of the initial request and make the colleague feel morally attacked.\[[@ref22]\] In addition, such a rebut will sound obnoxiously self-righteous."\[[@ref22]\] This way, the junior will be able to avoid participating in an unethical practice without harming relationships with colleagues.\[[@ref22]\] Following the enunciation of ICMJE criteria for authorship, several journals have taken various steps \[[Table 2](#T2){ref-type="table"}\] to ensure compliance with these criteria. They ensure that authors are made aware of the criteria, so that lack of information\[[@ref6][@ref13][@ref23]\] would not be the reason for non-compliance.

Despite the presence of guidelines on authorship, it is not uncommon to find that these are often breached\[[@ref17]\] and that the number of authors per article has not shown a decline in the post-ICMJE period.\[[@ref24]--[@ref29]\] We have to wait for more evidence before we make a definitive statement regarding the effectiveness of the ICMJE initiative, but the reasons for limited effect are not far to seek. The guidelines have their limitations. For example, it is not totally objective. How is one supposed to measure "*substantial contributions* to conception and design...." or "revising it critically for *important intellectual content*"? The Code does not provide any guidance regarding order of authorships. It also suffers from the inherent limitation of being "voluntary" in nature. It is highly dependent on values and ethics of individuals or groups involved. It has been drafted assuming that free will, reason, and integrity prevail.\[[@ref18]\] The Code is unlikely to be effective in curbing unethical practices, if the victims choose to acquiesce and institutions and journals decide to look the other way. Many criticize the Code for being out of touch with the realities of modern research, perceive them to be irrelevant and unable to withstand the prevalent power equations and pressure to publish.\[[@ref17]\] Taking these objects into consideration, some researchers have suggested certain modifications. For example, Paneth\[[@ref30]\] suggested that the authorship tasks be divided into four sub-tasks: (a) concept and design, (b) research resources and data, (c) analysis and interpretation, and (d) writing. Based on this, there could be authors (who satisfy all the authorship criteria), contributing authors (who have helped in writing the manuscript and in "research resource and data" or "analysis and interpretation"), and acknowledged contributors (participation in any one of the four tasks listed above). Nevertheless, the ICMJE authorship criteria provide a tool in the hands of researchers to judge for themselves, if they or their co-workers qualify for authorship.

GHOST AUTHORSHIP {#sec1-4}
================

Ghost authors are those who participate in research, data analysis, and/or writing of a manuscript but are not named or disclosed in the author byline or acknowledgments.\[[@ref21]\] One form of ghost authorship is suppression of the contribution of a junior colleague (usually postgraduate student, postdoctoral fellow or junior researcher), who is not included in the author list despite having carried out the research and provided a draft manuscript. Another form of ghost authorship is the one wherein an individual not connected with the research study writes the first draft, works as the author\'s personal editor, and provides a better-quality manuscript and saves "author\'s" time. The third type is the most dangerous form. In this, a medical writer appointed by a pharmaceutical or device company writes the draft, which is approved by the company. The company then approaches a reputed scientist for allowing his name to be cited as the author of this piece. This "author" who plays a very minor (if any) role in the preparation of the manuscript, at times approves the proposal even without checking the manuscript content. The last example is the most sinister one, which is of gravest consequence for the society. The medical writer\'s contribution is not listed (neither in author byline nor in acknowledgements), thereby giving the impression that the expert whose name appears in the byline has carried out the research and written the manuscript.

Ghostwriting, which was a "dirty little secret" of the medical literature, has now grown to be a full-fledged industry.\[[@ref31]\] Gøtzsche *et al*.\[[@ref32]\] found that 75% of industry-sponsored trials were ghost-written, as they did not include the names of individuals who wrote the protocol, analyzed the study findings, or wrote the manuscript, in the list of authors or study group or writing committee members or in "acknowledgements." Industry has used ghost authorship to market several drugs.\[[@ref31][@ref33]\] The risk with ghost-written manuscripts is that the listed author may not have even read the manuscript or may not know what goes under his name. The company uses the reputation and the standing of renowned scientists to push its drugs for a fee, without the readers, editor, and reviewers coming to know of it. This is outright breach of trust. These actions will ultimately erode the public trust in clinical research, in journals that report research and in medicine, in general.\[[@ref34]\]

World Association of Medical Editors (WAME) considers the phenomenon of ghostwriting as dishonest and unacceptable.\[[@ref35]\] It bestows undeserved credibility to the paper that has been ghost written by a person employed by a pharmaceutical company. The readers perceive it as an unbiased article written by an academician. This deception in author list does not allow the discerning readers to assess the impact of bias in published research,\[[@ref31]\] when in actual reality, it is a manuscript written by the sponsor.

The other ethical issue is that the journals publish articles with the understanding that authors mentioned in the list have written the article and take responsibility for its content. This understanding is breached when the article is ghost-written and there is no way finding out to what extent the listed authors are aware of its contents, leave aside taking responsibility for the content.

Merely identifying the ghost author in the "acknowledgement" section does not recognize his role in toto; and worse, the tenuous link between the article and the guest author continues to be exaggerated with undue prestige being accorded to the article.

Medical ghostwriting is a threat to public health which currently takes place only due to the cooperation of researchers employed at academic medical centers. Hence, the primary responsibility of preventing this practice rests with the institutions although journals can also play an important role. It is worth noting that Lacasse and Leo\[[@ref31]\] found that only a minority of the top-50 academic institutions in the US banned ghostwriting explicitly. The institutions, journal editors, and funding agencies should initiate actions to discourage this pernicious practice \[[Table 3](#T3){ref-type="table"}\].

###### 

Steps to curb ghost-writing\[[@ref31][@ref35][@ref36]\]
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Authorship of a medical paper is a matter of pride that has to be deserved and earned, and declared.\[[@ref33]\] It is necessary for researchers to imbibe this principle. Journal editors and institutions should formulate and implement policies that will discourage any manipulation of authorship. If left unchecked, such unethical practices could lead to loss of credibility for everyone: researchers, pharmaceutical industry, journals, and funding agencies. Medical fraternity and general public will cease to have any faith in the manner any research is conducted. This is in no one\'s interest.
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